Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 14/20 | 0.53 |
| ▸ | PPARA | Q07869 | 11/20 | 0.51 |
| ▸ | PPARG | P37231 | 7/20 | 0.51 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.40 |
| ▸ | PTGES | O14684 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30977146 | 0.89 | PPARD (0.64) | PPARDPPARAPPARG | |
| SCHEMBL3811706 | 0.78 | PPARD (0.77) | PPARDPPARAPPARG | |
| SCHEMBL6493346 | 0.76 | PPARD (0.60) | PPARDPPARAPPARG | |
| SCHEMBL5728665 | 0.76 | PPARD (0.55) | PPARDPPARAPPARGABCB1 | |
| SCHEMBL5728669 | 0.76 | PPARD (0.55) | PPARDPPARAPPARGABCB1 | |
| SCHEMBL5512756 | 0.75 | PPARD (0.65) | PPARDPPARAPPARG | |
| SCHEMBL21991483 | 0.75 | MAOB (0.63) | PPARAPPARG | |
| SCHEMBL6197334 | 0.74 | PPARD (0.50) | PPARDPPARAPPARGPSEN1 | |
| SCHEMBL5513262 | 0.71 | PPARD (0.66) | PPARDPPARAPPARG | |
| SCHEMBL5513388 | 0.70 | PPARD (0.83) | PPARDPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060287378-A1 | Novel pyrroles and imidazoles | WARNER-LAMBERT COMPANY LLC | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287378-A1 | Novel pyrroles and imidazoles | PPIP5K2, PPIE, PPOX | PPARD 1067/4885PPARA 1347/4885PPARG 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.